Researchers identified 4 prepregnancy conditions that were associated with better pregnancy outcomes among patients with SLE.

HealthDay News — The U.S. Food and Drug Administration has launched the Chemical Contaminants Transparency Tool (CCT Tool), an online searchable database to evaluate potential health risks of ...

Asthma is linked to an increased risk of developing knee, hip, and hand OA, particularly among patients with higher social isolation and loneliness.

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

High ionized calcium levels were associated with an increased risk for hyperparathyroidism, especially among men.

HealthDay News — The total number of births in the United States in 2023 was 3,596,017, which was down 2 percent from 2022, according to the March 18 National Vital Statistics Reports, a publication ...

Relative to high-dose doxycycline, low-dose doxycycline is comparably effective but more tolerable for lymphocytic scarring alopecias.

The FDA has approved Tremfya (guselkumab) for the treatment of adults with moderately to severely active Crohn disease.

We explore the current guidance for osteoporosis screening in men, as well as barriers to access for both clinicians and patients.

Topline data were announced from pivotal phase 3 studies evaluating povorcitinib in adults with moderate to severe hidradenitis suppurativa.

Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age and older.

The FDA has cleared Magstim Horizon 3.0 TMS Therapy System as an adjunct for the treatment of MDD in adolescent patients aged 15 to 21 years.